Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,472
Recruiting: 1,283
Ph III recruiting: 130
Growth YoY: +4.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,642)

clinicaltrialsPublishedShowing 151–200 of 1,572 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07620275	Safety and Efficacy of KSVCBD Injection in Multiple Myeloma Expressing CD19 and/or BCMA	recruiting	Phase 1	9	Chinese PLA General HospitalOTHER	1	Sep 15, 2026	clinicaltrials
NCT04314752	Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities(MEDULLA)	recruiting	—	4,000	University of California, DavisOTHER	1	Sep 14, 2026